Lung Cancer Considered

LCC in French_Virtual Tumor Board - EFGR NSCLC (1)

Lung Cancer Considered

Show Notes

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Angela Botticella and Dr. Jean Yannis Perentes. The tumor board focuses on the management of resectable EGFR-mutant NSCLC.

Guests:

Angela Botticella, MD Radiational Oncologist Department of Radiation Oncology Gustave Roussy

Jean Yannis Perentes, MD, PhD Professor and Chief, Department of Thoracic Surgery University Hospital of Lausanne CHUV

More from Lung Cancer Considered

Oct 20, 2026

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.

Oct 16, 2026

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.

Oct 13, 2026

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of their careers.

Oct 9, 2026

The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the inaugural joint IASLC/EMRO workshop took place at the 2026 World Conference on Lung Cancer (WCLC) in Seoul.

Oct 6, 2026

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Chul Kim moderates a discussion in Korean about breakthrough advances in thoracic oncology presented at the conference with Dr. Ji-Youn Han, Dr. Tae Min Kim, and Dr. Sehhoon Park.

See all episodes →